Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773)

China flag China · Delayed Price · Currency is CNY
18.89
-0.22 (-1.15%)
Nov 1, 2024, 3:04 PM CST
7.57%
Market Cap 17.61B
Revenue (ttm) 4.37B
Net Income (ttm) 1.19B
Shares Out 919.78M
EPS (ttm) 1.30
PE Ratio 14.73
Forward PE 14.08
Dividend 0.38 (2.01%)
Ex-Dividend Date May 28, 2024
Volume 8,072,792
Open 19.10
Previous Close 19.11
Day's Range 18.87 - 19.25
52-Week Range 13.15 - 24.50
Beta 0.08
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Chengdu Kanghong Pharmaceutical Group

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, produces, and sells chemical drugs, chinese medicines, and biological products in China. It also develops ophthalmic medical devices. The company offers central nervous, digestive, and endocrine system drugs. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China. [Read more]

Sector Healthcare
Founded 1996
Employees 4,289
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002773
Full Company Profile

Financial Performance

In 2023, Chengdu Kanghong Pharmaceutical Group's revenue was 3.96 billion, an increase of 16.77% compared to the previous year's 3.39 billion. Earnings were 1.04 billion, an increase of 16.52%.

Financial Statements

News

There is no news available yet.